Study Warns of Rapid Weight Regain and Health Risks After Stopping Ozempic or Wegovy
# 18-Month Warning for Anyone Stopping Ozempic or Wegovy
A recent study highlights concerns for individuals using Ozempic and Wegovy, two medications that help with weight loss. Researchers from the BMJ found that those who stop taking these drugs may regain weight rapidly and could lose the health benefits they gained while on treatment.
The research indicates that continuous use of semaglutide, the active ingredient in both medications, significantly helps reduce cardiovascular risks. In fact, it was shown that "continuous use of semaglutide over four years reduced major cardiovascular disease events in individuals with existing cardiovascular disease." This underscores the importance of maintaining treatment for those who need it.
The researchers further explained the implications of stopping treatment. They noted, "We have shown that weight regain is faster (0.8 kg/month) and a return to baseline weight projected at 1.5 years after cessation of treatment, implying that the benefits on cardiovascular health will probably also attenuate more rapidly." This suggests that individuals may not only experience weight gain but also face increased health risks if they discontinue use.
Health experts advise those considering stopping their medications to consult their healthcare providers to understand the potential consequences better. If you're thinking about changing your medication regimen, contact your GP or the NHS for guidance.
This article is for general information only and is not a substitute for professional medical advice. Always speak to a GP or qualified health professional about your own health.